ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Hodgkin Lymphoma in Durham, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia
B-Cell Chronic Lymphocytic Leukemia
Lymphoid Leukemia
Cancer

Non-Hodgkin Lymphoma trials near Durham, NC, USA:

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Study J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed orig...

Enrolling
Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Drug: Pirtobrutinib

Phase 4

Lilly
Lilly

Durham, North Carolina, United States and 34 other locations

Locations recently updated

This is an open-label, multi-center Phase 1b clinical study of oral AS-1763 (docirbrutinib) in patients with CLL/SLL or B-cell NHL who have failed or...

Enrolling
Marginal Zone Lymphoma
Follicular Lymphoma
Drug: Docirbrutinib

Phase 1

Carna Biosciences

Durham, North Carolina, United States and 11 other locations

This study has 2 parts.The main aim of Part 1 is to check for side effects from TAK-007 in adults with relapsed or refractory (r/r) B-cell Non...

Active, not recruiting
Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Drug: Chemotherapy Agents
Biological: TAK-007

Phase 2

Takeda
Takeda

Durham, North Carolina, United States and 14 other locations

This is a Phase 1/1b, nonrandomized, open-label, parallel assignment, dose-escalation, and dose-expansion study to evaluate the safety and clinical a...

Enrolling
Non-Hodgkin Lymphoma
B-cell Acute Lymphoblastic Leukemia
Drug: Cyclophosphamide
Drug: Fludarabine

Phase 1

Imugene

Durham, North Carolina, United States and 21 other locations

The primary purpose of the study is to evaluate whether biweekly administered XEMBIFY® plus Standard Medical Treatment (SMT) over a one-year period w...

Enrolling
Non-Hodgkin Lymphoma
Multiple Myleoma
Drug: Xembify
Drug: Placebo

Phase 3

Grifols
Grifols

Morrisville, North Carolina, United States and 56 other locations

This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirtobrutinib) in patients with CLL/SLL and NHL who have failed or are intolera...

Active, not recruiting
Marginal Zone Lymphoma
Small Lymphocytic Lymphoma
Drug: Venetoclax
Drug: Rituximab

Phase 1, Phase 2

Loxo Oncology
Loxo Oncology

Durham, North Carolina, United States and 55 other locations

DS-3201b is an experimental drug that is being investigated in clinical research.Adults with non-Hodgkin lymphoma (NHL) ma...

Active, not recruiting
Lymphoma, Malignant
Non-hodgkin Lymphoma
Drug: DS-3201b

Phase 1

Daiichi Sankyo
Daiichi Sankyo

Durham, North Carolina, United States and 20 other locations

The study is focused on patients with diffuse large B-cell lymphoma (DLBCL) that have not been treated before (called "previously untreated"...

Active, not recruiting
Diffuse Large B-cell Lymphoma (DLBCL)
Drug: Doxorubicin
Drug: Prednisone/Prednisolone

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Durham, North Carolina, United States and 149 other locations

The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after compl...

Enrolling
Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Drug: Pirtobrutinib

Phase 4

Lilly
Lilly

Durham, North Carolina, United States and 34 other locations

is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL)....

Enrolling
Follicular Lymphoma (FL)
Drug: Odronextamab
Drug: Rituximab

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Chapel Hill, North Carolina, United States and 188 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems